Physician profile
James S Brewer
NPI 1336403286
$1,069.08
in general payments reported to CMS, 2019-2025
12 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $51.96 · 2021: $164 · 2022: $191 · 2023: $194 · 2024: $128 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $408.55 | 2019-2025 | Total30, Precision 1, Precision7 |
| Coopervision INC. | $200.98 | 2021-2025 | Misight Contact Lens |
| Novartis Pharmaceuticals Corporation | $84.14 | 2022-2023 | |
| Allergan, INC. | $76.95 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $74.64 | 2021-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $57.92 | 2019-2021 | |
| Abbvie INC. | $39.65 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $34.18 | 2024-2025 | Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $28.16 | 2024 | Xdemvy |
| Harrow Eye, LLC | $22.90 | 2024 | |
| Sun Pharmaceutical Industries INC. | $20.62 | 2019 | |
| Biotissue Holdings INC. | $20.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.